From Tradition to Trend: Scrutinizing the Logic behind Plant-based Drug Discovery
Darshan Gowda Bharathi Srinivasa1, Sunil Kumar Kadiri1, Prashant Tiwari1
1Department of Pharmacology, College of Pharmaceutical Sciences, Dayananda Sagar University, Bengaluru South, Karnataka, 562112, India.
Current Drug Research Reviews
|May 15, 2026
Summary
Plant pharmacology research is rapidly advancing drug discovery, offering therapeutic breakthroughs. This review assesses the scientific, economic, and ethical impacts of plant-based medicine development.
Area of Science:
- Pharmacology
- Drug Discovery
- Ethnobotany
Background:
- Revival of plant pharmacological research driven by interest in drug discovery and therapeutic breakthroughs.
- Historical use of plant-derived chemicals in medicine accelerated by technological advancements.
- Growing field of plant-based medicine necessitates critical examination of its consequences.
Purpose of the Study:
- Critically examine the rapid rise of plant-based medicine.
- Assess scientific, economic, and ethical implications.
- Establish the justification for this developing field.
Main Methods:
- Review of current research trends in plant pharmacology.
- Analysis of challenges including standardization and bioavailability.
- Comparative efficacy assessment of synthetic versus plant-based medications.
Main Results:
- Technological improvements are accelerating research and development of plant-derived drugs.
- Biotechnology, AI, and sustainable practices are crucial for drug development.
- Interdisciplinary approaches can enhance the legitimacy and relevance of plant pharmacology.
Conclusions:
- Plant pharmacology's trajectory requires assessment for scientific justification and economic viability.
- Ongoing challenges exist, but interdisciplinary efforts can improve the field.
- Future potential of plant-derived drugs is significant, warranting continued investigation.
Related Concept Videos
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...


